AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22187386 — intervention group
Group type: COMPARATOR
Intervention: Monark Peak Bike
Number of subjects: 40
Study 20124229 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac, 50 mg, twice daily for 14 days
Number of subjects: 196
Study 20124229 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 14 days
Number of subjects: 196
Study 20124229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 20124229 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 196
Study 18929701 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 816
Study 18929701 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 816
Study 15982123 — intervention group
Group type: EXPERIMENTAL
Intervention: Distorted face viewing
Number of subjects: 0
Study 15982123 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in contrast polarity or spatial frequency
Number of subjects: 0
Study 15982123 — intervention group
Group type: EXPERIMENTAL
Intervention: Face aftereffects
Number of subjects: 0
Study 15982123 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation processes
Number of subjects: 0
Study 15456046 — intervention group
Group type: EXPERIMENTAL
Intervention: F.E.D. method
Number of subjects: 30
Study 15456046 — intervention group
Group type: COMPARATOR
Intervention: Traditional orthopaedic methods
Number of subjects: 30
Study 10510993 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein with 62 mg of isoflavones
Number of subjects: 156
Study 10510993 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein with 37 mg of isoflavones
Number of subjects: 156
Study 10510993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-extracted isolated soy protein containing 3 mg of isoflavones
Number of subjects: 156
Study 10510993 — intervention group
Group type: COMPARATOR
Intervention: Casein (control)
Number of subjects: 156
Study 8748255 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 (single intravenous injection)
Number of subjects: 0
Study 8748255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1889712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + De‐Noltab (tripotassium dicitrato bismuthate)
Number of subjects: 12
Study 1889712 — intervention group
Group type: COMPARATOR
Intervention: Placebo + De‐Noltab (tripotassium dicitrato bismuthate)
Number of subjects: 12
Study 1889712 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Pepto‐Bismol (bismuth salicylate)
Number of subjects: 12
Study 1889712 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Roter (bismuth subnitrate)
Number of subjects: 12
Study 1889712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + Pepto‐Bismol (bismuth salicylate)
Number of subjects: 12
Study 1889712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + Roter (bismuth subnitrate)
Number of subjects: 12
Study 6210835 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive mobilisation and manipulation of the lumbar spine
Number of subjects: 48
Study 6210835 — intervention group
Group type: COMPARATOR
Intervention: Microwave diathermy, isometric abdominal exercises, and ergonomic instructions
Number of subjects: 48
Study 31393313 — intervention group
Group type: EXPERIMENTAL
Intervention: Demodex colonization (n=30)
Number of subjects: 88
Study 31393313 — intervention group
Group type: COMPARATOR
Intervention: No Demodex colonization (n=58)
Number of subjects: 88
Study 31393313 — intervention group
Group type: EXPERIMENTAL
Intervention: Demodex colonization
Number of subjects: 88
Study 31087255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' report of dentifrice amount
Number of subjects: 334
Study 31087255 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight of dentifrice on toothbrush
Number of subjects: 334
Study 27173580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone gas (32 g m-3)
Number of subjects: 60
Study 27173580 — intervention group
Group type: COMPARATOR
Intervention: NaOCl (3%) followed by CHX (2%)
Number of subjects: 60
Study 27173580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone gas
Number of subjects: 60
Study 27173580 — intervention group
Group type: COMPARATOR
Intervention: NaOCl/CHX
Number of subjects: 60
Study 25693987 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity (LF) instruction
Number of subjects: 0
Study 25693987 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) instruction
Number of subjects: 0
Study 25693987 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23559359 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 59
Study 23559359 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 59
Study 22509297 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-containing ART
Number of subjects: 444
Study 22509297 — intervention group
Group type: COMPARATOR
Intervention: PI-sparing ART
Number of subjects: 444
Study 19031301 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare metal stent implantation
Number of subjects: 0
Study 17331264 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual 13 week training program based on the ten percent training rule
Number of subjects: 0
Study 17331264 — intervention group
Group type: COMPARATOR
Intervention: Standard 8 week training program
Number of subjects: 0
Study 15925955 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 100
Study 15925955 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement plus Snacks (MRPS)
Number of subjects: 100
Study 12118642 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (50 microg)
Number of subjects: 250
Study 12118642 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol (100 microg)
Number of subjects: 250
Study 10518976 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (5 x 3.3 Gy, 9 MeV photons)
Number of subjects: 94
Study 10518976 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 94
Study 10518976 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative irradiation)
Number of subjects: 94
Study 10518976 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (if risk factors present)
Number of subjects: 94
Study 10518976 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperatively irradiated patients with risk factors
Number of subjects: 94
Study 7733345 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (0.04 mg/kg i.v.)
Number of subjects: 39
Study 7733345 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.2 mg/kg i.v.)
Number of subjects: 39
Study 7733345 — intervention group
Group type: EXPERIMENTAL
Intervention: Double autonomic blockade (Atropine + Propranolol)
Number of subjects: 39
Study 2252732 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline insertion site with straight intraperitoneal segment catheter
Number of subjects: 85
Study 2252732 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral rectus muscle insertion site with spiral intraperitoneal segment catheter
Number of subjects: 85
Study 2252732 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall catheter complications
Number of subjects: 85
Study 2252732 — intervention group
Group type: EXPERIMENTAL
Intervention: Late catheter removals due to peritonitis episodes
Number of subjects: 85
Study 7214807 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g fractionated dose of iopanoic acid (Telepaque)
Number of subjects: 100
Study 7214807 — intervention group
Group type: COMPARATOR
Intervention: Sodium ipodate (Biloptin)
Number of subjects: 100
Study 31291276 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-involvement condition
Number of subjects: 118
Study 31291276 — intervention group
Group type: COMPARATOR
Intervention: Low self-involvement condition
Number of subjects: 118
Study 31291276 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 118
Study 31291276 — intervention group
Group type: COMPARATOR
Intervention: Young adults
Number of subjects: 118
Study 28980579 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological computer programs
Number of subjects: 68
Study 28980579 — intervention group
Group type: COMPARATOR
Intervention: Entertainment computer games
Number of subjects: 68
Study 28980579 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 68
Study 26034931 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of moxifloxacin per os once daily for 7 days
Number of subjects: 39
Study 26034931 — intervention group
Group type: COMPARATOR
Intervention: 500 mg of metronidazole and 500 mg amoxicillin per os three times daily for 7 days
Number of subjects: 39
Study 23118430 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 16
Study 21645573 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at birth, 1 and 2 months
Number of subjects: 318
Study 21645573 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at 1, 2 and 3 months
Number of subjects: 318
Study 21645573 — intervention group
Group type: COMPARATOR
Intervention: 7-valent pneumococcal conjugate vaccination (7vPCV) at birth
Number of subjects: 318
Study 21645573 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 318
Study 18795905 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based consultations (remote dermatology consultations through a secure web-based communication system)
Number of subjects: 98
Study 18795905 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (general practitioner visits and hospital care)
Number of subjects: 98
Study 18795905 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 98
Study 18795905 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based consultations
Number of subjects: 98
Study 17334508 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group (SMG)
Number of subjects: 195
Study 17334508 — intervention group
Group type: COMPARATOR
Intervention: Routine care group (RCG)
Number of subjects: 195
Study 17334508 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study 12671775 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy provided at different study centers
Number of subjects: 0
Study 12671775 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline viral load, lower nonnucleoside reverse transcriptase inhibitor resistance, lower protease inhibitor resistance
Number of subjects: 0
Study 12671775 — intervention group
Group type: EXPERIMENTAL
Intervention: Study sites divided into two groups based on Week 12 HIV RNA values
Number of subjects: 0
Study 10993428 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (Pan) 80 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Number of subjects: 172
Study 10993428 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (Ome) 40 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Number of subjects: 172
Study 9195642 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial nursing intervention (weekly postoperative telephone follow-up, evaluation and counseling by a psychiatric liaison nurse, participation in an ICD support group)
Number of subjects: 34
Study 9195642 — intervention group
Group type: COMPARATOR
Intervention: Usual postoperative care and follow-up (control group)
Number of subjects: 34
Study 1603539 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub‐tenon's injections of methylprednisolone acetate (20 mg) along with topical 1% prednisolone acetate and 1% atropine
Number of subjects: 3
Study 3890818 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin
Number of subjects: 32
Study 3890818 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone
Number of subjects: 32
Study 31167872 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART cognitive training
Number of subjects: 60
Study 31167872 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study 30547822 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultivars of banana and plantain; 87 locally recognized cultivars identified: 73 banana and 14 plantain.
Number of subjects: 51
Study 30547822 — intervention group
Group type: EXPERIMENTAL
Intervention: Production constraints identified; main biotic challenges: banana weevil (Cosmopolites sordidus) and banana bunchy top virus (BBTV); abiotic problems: drought and wind.
Number of subjects: 51
Study 30547822 — intervention group
Group type: EXPERIMENTAL
Intervention: Local varieties; some local varieties like Amandan, Assonwonnou, Coleti, and Ninkouin are extremely rare.
Number of subjects: 51
Study 26503737 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate (Ca2) with probiotic (Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011)
Number of subjects: 32
Study 26503737 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (Ca1) with probiotic
Number of subjects: 32
Study 26503737 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic alone
Number of subjects: 32
Study 26503737 — intervention group
Group type: COMPARATOR
Intervention: Calcium phosphate (Ca2)
Number of subjects: 32
Study 26503737 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (Ca1)
Number of subjects: 32
Study 24387872 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 45
Study 24387872 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy (CPT)
Number of subjects: 45
Study 22348910 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antifungal treatment plus pessary capsules containing 200 mg GMH (twice a week for thirty days)
Number of subjects: 26
Study 22348910 — intervention group
Group type: COMPARATOR
Intervention: Standard antifungal treatment
Number of subjects: 26
Study 20102847 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain RTE oat cereal (3 g/day oat b‐glucan)
Number of subjects: 204
Study 20102847 — intervention group
Group type: COMPARATOR
Intervention: Control (energy-matched low-fiber foods)
Number of subjects: 204
Study 19253862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocimum sanctum leaf extract (500 mg/capsule, twice daily, p.o. after meal)
Number of subjects: 35
Study 16433396 — intervention group
Group type: EXPERIMENTAL
Intervention: AElite Fil
Number of subjects: 15
Study 16433396 — intervention group
Group type: EXPERIMENTAL
Intervention: AElite Flo
Number of subjects: 15
Study 16433396 — intervention group
Group type: COMPARATOR
Intervention: Both materials
Number of subjects: 15
Study 12598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 34 degrees C for the first 12 hours of ECMO
Number of subjects: 20
Study 12598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 35 degrees C for the first 12 hours of ECMO
Number of subjects: 20
Study 12598502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia at 36 degrees C for the first 12 hours of ECMO
Number of subjects: 20
Study 12598502 — intervention group
Group type: COMPARATOR
Intervention: Control group at 37 degrees C
Number of subjects: 20
Study 10100104 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 400-800 mg once a day
Number of subjects: 243
Study 10100104 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 200-400 mg twice a day
Number of subjects: 243
Study 10100104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 8777120 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 120 micrograms with fentanyl 50 micrograms
Number of subjects: 28
Study 8777120 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine (25 mg)
Number of subjects: 28
Study 1856404 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and dipyridamole
Number of subjects: 247
Study 1856404 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (placebo)
Number of subjects: 247
Study 1856404 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical characteristics (severity of angina)
Number of subjects: 247
Study 1856404 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic characteristics (percent diameter stenosis before angioplasty, stenosis greater than 10 mm in length, calcific stenosis)
Number of subjects: 247
Study 1856404 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual percent diameter stenosis and residual mean pressure gradient
Number of subjects: 247
Study 1856404 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stenosis and residual percent diameter stenosis
Number of subjects: 247
Study 6668409 — intervention group
Group type: EXPERIMENTAL
Intervention: PGF2 alpha gel 5 mg
Number of subjects: 90
Study 6668409 — intervention group
Group type: EXPERIMENTAL
Intervention: PGF2 alpha gel 2.5 mg
Number of subjects: 90
Study 6668409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 29616398 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic spectral imaging protocol selection (ASIS) plus 50% adaptive statistical iterative reconstruction (ASIR)
Number of subjects: 64
Study 29616398 — intervention group
Group type: COMPARATOR
Intervention: Control group with 120 kVp voltage
Number of subjects: 64
Study 27521979 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200mg twice daily for eight weeks
Number of subjects: 116
Study 27521979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 24937019 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research conducted concurrently with RCTs
Number of subjects: 15
Study 24937019 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback of interim or final qualitative findings to trial team members
Number of subjects: 15
Study 22490878 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 31350
Study 22490878 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 31350
Study 22490878 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 31350
Study 22490878 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone, Amlodipine, Lisinopril
Number of subjects: 31350
Study 20469573 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor re-education intervention
Number of subjects: 0
Study 18381952 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial telephone counseling (PTC) intervention
Number of subjects: 50
Study 18381952 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 16060200 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 11
Study 16060200 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (Prozac)
Number of subjects: 11
Study 16060200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 16060200 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome measures
Number of subjects: 11
Study 16060200 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse drug reactions, clinical global impression (CGI), HAMD, mini international psychiatric Interview, Pittsburgh sleep quality index, Side‐effects checklist, Short Form 12, treatment credibility questionnaire, work and social disability scale
Number of subjects: 11
Study 12021004 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic motion analysis system
Number of subjects: 4
Study 10407522 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg and midazolam 0.05 mg/kg (group I)
Number of subjects: 60
Study 10407522 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg and midazolam 0.1 mg/kg (group II)
Number of subjects: 60
Study 8773212 — intervention group
Group type: EXPERIMENTAL
Intervention: maprotiline (n = 15)
Number of subjects: 33
Study 8773212 — intervention group
Group type: COMPARATOR
Intervention: fluvoxamine (n = 18)
Number of subjects: 33
Study 2343795 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertiveness Training with Behavioral Practice (ATBP)
Number of subjects: 43
Study 2343795 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertiveness Training with Journal (ATJ)
Number of subjects: 43
Study 2343795 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 43
Study 7380107 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet regulation and 0.5 g tolbutamide t.i.d. (N = 49)
Number of subjects: 267
Study 7380107 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet regulation and one placebo tablet t.i.d. (N = 48)
Number of subjects: 267
Study 7380107 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet regulation only (N = 50)
Number of subjects: 267
Study 7380107 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment (N = 61)
Number of subjects: 267
Study 7380107 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment, OGTT at follow-up (N = 59)
Number of subjects: 267
Study 7380107 — intervention group
Group type: COMPARATOR
Intervention: Normal OGTT control group (N = 52)
Number of subjects: 267
Study 30710769 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging only
Number of subjects: 10
Study 30710769 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging then freezing/thawing
Number of subjects: 10
Study 30710769 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing then thaw/aging
Number of subjects: 10
Study 30710769 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing treatments (both aging then freezing/thawing and freezing then thaw/aging)
Number of subjects: 10
Study 28658329 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adherent Ibuprofen foam dressing (IFD)
Number of subjects: 80
Study 28658329 — intervention group
Group type: COMPARATOR
Intervention: Primary dressing (Control Group)
Number of subjects: 80
Study 24921163 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 18
Study 24921163 — intervention group
Group type: COMPARATOR
Intervention: Comparison group of overweight women without PCOS
Number of subjects: 18